Lineage Cell Therapeutics Inc (LCTX)

Lineage Cell Therapeutics Inc (LCTX) is a Biotechnology company in the Healthcare sector listed on the AMEX.

As of Oct 23, 2026: market cap $251M; returns 1 day +1.5%, 1 week +2.2%, 1 year -38.7%.

Lineage Cell Therapeutics is a clinical-stage biotechnology company specializing in the development of allogeneic (off-the-shelf) cell transplant therapies intended to replace functional cells lost to degenerative diseases or traumatic injury.

Groups LCTX belongs to

• Biotechnology
• Regenerative Medicine
• Clinical Stage Biotech
• Life Sciences
• Healthcare
• Clinical Stage
• Biopharmaceutical
• Ophthalmology
• Neuroscience
• Strategic Partnerships

LCTX financial model: income statement, cash flow and balance sheet